Shiping Guo

1.1k total citations
9 papers, 149 citations indexed

About

Shiping Guo is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Surgery. According to data from OpenAlex, Shiping Guo has authored 9 papers receiving a total of 149 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pulmonary and Respiratory Medicine, 3 papers in Molecular Biology and 2 papers in Surgery. Recurrent topics in Shiping Guo's work include RNA modifications and cancer (2 papers), Esophageal and GI Pathology (2 papers) and Lung Cancer Diagnosis and Treatment (2 papers). Shiping Guo is often cited by papers focused on RNA modifications and cancer (2 papers), Esophageal and GI Pathology (2 papers) and Lung Cancer Diagnosis and Treatment (2 papers). Shiping Guo collaborates with scholars based in China, United States and Hong Kong. Shiping Guo's co-authors include Hongjie Zhang, Qishi Song, Heyang Cui, Yikun Cheng, Yongping Cui, Yu Qian, Ting Yan, Pengzhou Kong, Xiaolong Cheng and Xiaofei Zhuang and has published in prestigious journals such as Cell Death and Disease, Theranostics and Fitoterapia.

In The Last Decade

Shiping Guo

9 papers receiving 144 citations

Peers

Shiping Guo

MB

CAM

PRM

TOXIC

ONCOL

Hyeon Jin Kim South Korea

Xiucheng Li China

Liang‐Cai Wu China

Huda Fatima Rajani Iran

Mengting Yu China

Fatheya Zahran Egypt

Kah Min Yap Malaysia

Raed Alserihi Saudi Arabia

Junli Zhang China

Niraj Babu India

Hyeon Jin Kim South Korea

Shiping Guo

148 ×2.3

MB

36 ×1.1

CAM

26 ×0.8

PRM

25 ×0.8

TOXIC

37 ×1.6

ONCOL

Citations per year, relative to Shiping Guo Shiping Guo (= 1×) peers Hyeon Jin Kim

Countries citing papers authored by Shiping Guo

Since Specialization

Citations

This map shows the geographic impact of Shiping Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shiping Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shiping Guo more than expected).

Fields of papers citing papers by Shiping Guo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shiping Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shiping Guo. The network helps show where Shiping Guo may publish in the future.

Co-authorship network of co-authors of Shiping Guo

This figure shows the co-authorship network connecting the top 25 collaborators of Shiping Guo. A scholar is included among the top collaborators of Shiping Guo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shiping Guo. Shiping Guo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Li, Chao, et al.. (2024). Benefits of camrelizumab plus carboplatin and albumin paclitaxel as induction therapy for locally advanced borderline resectable or unresectable esophageal squamous cell carcinoma. Thoracic Cancer. 15(8). 622–629. 4 indexed citations

2.

Zhuang, Xiaofei, et al.. (2022). Design and synthesis of copper nanoparticles for the treatment of human esophageal cancer: introducing a novel chemotherapeutic supplement. Journal of Experimental Nanoscience. 17(1). 274–284. 11 indexed citations

3.

Chen, Gang, Zhifeng Zheng, Junsheng Li, et al.. (2021). Long non‑coding RNA PITPNA‑AS1 silencing suppresses proliferation, metastasis and epithelial‑mesenchymal transition in non‑small cell lung cancer cells by targeting microRNA‑32‑5p. Molecular Medicine Reports. 23(3). 7 indexed citations

4.

Chen, Yun, et al.. (2021). Primary EWS/PNET of the lung with TP53 germline and SKT11 somatic mutation: A case report and review of the literature. Thoracic Cancer. 13(1). 137–140. 2 indexed citations

5.

Qian, Yu, Pengzhou Kong, Yikun Cheng, et al.. (2020). Elevated DHODH expression promotes cell proliferation via stabilizing β-catenin in esophageal squamous cell carcinoma. Cell Death and Disease. 11(10). 862–862. 28 indexed citations

6.

Kong, Pengzhou, Enwei Xu, Yanghui Bi, et al.. (2020). Novel ESCC-related gene ZNF750 as potential Prognostic biomarker and inhibits Epithelial-Mesenchymal Transition through directly depressing SNAI1 promoter in ESCC. Theranostics. 10(4). 1798–1813. 28 indexed citations

7.

Kang, Zheng, et al.. (2020). Effectiveness and postoperative pain level of single-port versus two-port thoracoscopic lobectomy for lung cancer: a retrospective cohort study. General Thoracic and Cardiovascular Surgery. 69(2). 318–325. 13 indexed citations

8.

Song, Qishi, et al.. (2008). Antimicrobial anthraquinones from Morinda angustifolia. Fitoterapia. 79(7-8). 501–504. 55 indexed citations

9.

Guo, Shiping, Hongguang Zhang, Yanyan Ma, & Chunli Wang. (2007). [Cervical esophagogastrostomy with circular mechanical stapler in the treatment of esophageal carcinoma--report of 346 cases].. PubMed. 29(2). 151–3. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact